BABAK ATTARAN REZAEI: Open Payments
NPI 1205141041 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,998 in 95 payments from 27 companies in 2025. Trend: 2023 $1,569 · 2024 $1,632 · 2025 $1,998
Food & beverage: $1,998
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 17 | $353 |
| UCB, Inc. | 13 | $252 |
| JAZZ PHARMACEUTICALS INC. | 11 | $210 |
| PFIZER INC. | 10 | $154 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| Genentech USA, Inc. | 3 | $86 |
| TG Therapeutics, Inc. | 3 | $84 |
| Eisai Inc. | 3 | $81 |
| ACADIA Pharmaceuticals Inc | 3 | $80 |
| Grifols USA, LLC | 2 | $65 |
Products named: Fintepla, EPIDIOLEX, NURTEC ODT, Symbravo, Ocrevus Zunovo, BRIUMVI, Leqembi, DAYBUE.
Industry payments across TX — which companies pay providers there.
